{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:09:25Z","timestamp":1792012165198,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"T\u00fcrk Dermatoloji Derne\u011fi","award":["17-865"],"award-info":[{"award-number":["17-865"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00403-019-02012-w","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T15:02:32Z","timestamp":1573657352000},"page":"187-196","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Serum IL-36\u03b1, IL-36\u03b2, and IL-36\u03b3 levels in patients with hidradenitis suppurativa: association with disease characteristics, smoking, obesity, and metabolic syndrome"],"prefix":"10.1007","volume":"312","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-7285","authenticated-orcid":false,"given":"Y.","family":"Hayran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"All\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c7.","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Akdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Turhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"key":"2012_CR1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/bjd.17151","volume":"180","author":"M Argyropoulou","year":"2019","unstructured":"Argyropoulou M, Kanni T, Kyprianou M, Melachroinopoulos N, Giamarellos-Bourboulis EJ (2019) Cost-savings of adalimumab in hidradenitis suppurativa: a retrospective analysis of a real-world cohort. Br J Dermatol 180:1161\u20131168","journal-title":"Br J Dermatol"},{"key":"2012_CR2","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9149(02)02284-1","volume":"89","author":"EA Bermudez","year":"2002","unstructured":"Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM (2002) Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89:1117\u20131119","journal-title":"Am J Cardiol"},{"key":"2012_CR3","doi-asserted-by":"crossref","first-page":"e12737","DOI":"10.1111\/dth.12737","volume":"31","author":"V Bettoli","year":"2018","unstructured":"Bettoli V, Manfredini M, Calamo G et al (2018) Long-term adalimumab treatment of hidradenitis suppurativa: Results and practical insights from a real-life experience. Dermatol Ther 31:e12737","journal-title":"Dermatol Ther"},{"key":"2012_CR4","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.4049\/jimmunol.1000313","volume":"185","author":"H Blumberg","year":"2010","unstructured":"Blumberg H, Dinh H, Dean C Jr et al (2010) IL-1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 185:4354\u20134362","journal-title":"J Immunol"},{"key":"2012_CR5","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1084\/jem.20070157","volume":"204","author":"H Blumberg","year":"2007","unstructured":"Blumberg H, Dinh H, Trueblood ES et al (2007) Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 204:2603\u20132614","journal-title":"J Exp Med"},{"key":"2012_CR6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","volume":"184","author":"MA Boutet","year":"2016","unstructured":"Boutet MA, Bart G, Penhoat M et al (2016) Distinct expression of interleukin (IL)-36\u03b1, \u03b2 and \u03b3, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn\u2019s disease. Clin Exp Immunol 184:159\u2013173","journal-title":"Clin Exp Immunol"},{"key":"2012_CR7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/exd.13228","volume":"26","author":"C Bridgewood","year":"2017","unstructured":"Bridgewood C, Stacey M, Alase A, Lagos D, Graham A, Wittmann M (2017) IL-36\u03b3 has proinflammatory effects on human endothelial cells. Exp Dermatol 26:402\u2013408","journal-title":"Exp Dermatol"},{"key":"2012_CR8","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/jid.2011.234","volume":"131","author":"Y Carrier","year":"2011","unstructured":"Carrier Y, Ma HL, Ramon HE et al (2011) Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Investig Dermatol 131:2428\u20132437","journal-title":"J Investig Dermatol"},{"key":"2012_CR9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1165\/rcmb.2010-0075OC","volume":"45","author":"RT Chustz","year":"2011","unstructured":"Chustz RT, Nagarkar DR, Poposki JA et al (2011) Regulation and function of the IL-1 family cytokine IL-1F9 in human bronchial epithelial cells. Am J Respir Cell Mol Biol 45:145\u2013153","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2012_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jaad.2016.08.031","volume":"76","author":"IE Deckers","year":"2017","unstructured":"Deckers IE, Benhadou F, Koldijk MJ et al (2017) Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study. J Am Acad Dermatol 76:49\u201353","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR11","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/jid.2014.532","volume":"135","author":"AM D\u2019Erme","year":"2015","unstructured":"D\u2019Erme AM, Wilsmann-Theis D, Wagenpfeil J et al (2015) IL-36\u03b3 (IL-1F9) is a biomarker for psoriasis skin lesions. J Investig Dermatol 135:1025\u20131032","journal-title":"J Investig Dermatol"},{"key":"2012_CR12","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00403-017-1769-5","volume":"309","author":"R Di Caprio","year":"2017","unstructured":"Di Caprio R, Balato A, Caiazzo G et al (2017) IL-36 cytokines are increased in acne and hidradenitis suppurativa. Arch Dermatol Res 309:673\u2013678","journal-title":"Arch Dermatol Res"},{"key":"2012_CR13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1001\/archdermatol.2011.315","volume":"148","author":"B Dr\u00e9no","year":"2012","unstructured":"Dr\u00e9no B, Khammari A, Brocard A et al (2012) Hidradenitis suppurativa: the role of deficient cutaneous innate immunity. Arch Dermatol 148:182\u2013186","journal-title":"Arch Dermatol"},{"key":"2012_CR14","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults","year":"2001","unstructured":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (2001) Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486\u20132497","journal-title":"JAMA"},{"key":"2012_CR15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0801792","volume":"25","author":"A Festa","year":"2001","unstructured":"Festa A, D\u2019Agostino R Jr, Williams K et al (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25:1407\u20131415","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2012_CR16","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.4049\/jimmunol.1301481","volume":"192","author":"AM Foster","year":"2014","unstructured":"Foster AM, Baliwag J, Chen CS et al (2014) IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin. J Immunol 192:6053\u20136061","journal-title":"J Immunol"},{"key":"2012_CR17","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0195-668X(03)00260-4","volume":"24","author":"M Fr\u00f6hlich","year":"2003","unstructured":"Fr\u00f6hlich M, Sund M, L\u00f6wel H, Imhof A, Hoffmeister A, Koenig W (2003) Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994\/95). Eur Heart J 24:1365\u20131372","journal-title":"Eur Heart J"},{"key":"2012_CR18","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jaad.2015.08.052","volume":"73","author":"S Hessam","year":"2015","unstructured":"Hessam S, Sand M, Gambichler T, Bechara FG (2015) Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol 73:998\u20131005","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.16019","volume":"178","author":"S Hessam","year":"2018","unstructured":"Hessam S, Sand M, Gambichler T, Skrygan M, R\u00fcddel I, Bechara FG (2018) Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop. Br J Dermatol 178:761\u2013767","journal-title":"Br J Dermatol"},{"key":"2012_CR20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1172\/JCI117936","volume":"95","author":"GS Hotamisligil","year":"1995","unstructured":"Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Investig 95:2409\u20132415","journal-title":"J Clin Investig"},{"key":"2012_CR21","doi-asserted-by":"crossref","first-page":"2450401","DOI":"10.1155\/2017\/2450401","volume":"2017","author":"D Jim\u00e9nez-Gallo","year":"2017","unstructured":"Jim\u00e9nez-Gallo D, de la Varga-Mart\u00ednez R, Ossorio-Garc\u00eda L, Albarr\u00e1n-Planelles C, Rodr\u00edguez C, Linares-Barrios M (2017) The clinical significance of increased serum proinflammatory cytokines, c-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa. Mediat Inflamm 2017:2450401","journal-title":"Mediat Inflamm"},{"key":"2012_CR22","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.1003162","volume":"186","author":"A Johnston","year":"2011","unstructured":"Johnston A, Xing X, Guzman AM et al (2011) IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 186:2613\u20132622","journal-title":"J Immunol"},{"key":"2012_CR23","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/bjd.13270","volume":"171","author":"AB Kimball","year":"2014","unstructured":"Kimball AB, Jemec GB, Yang M et al (2014) Assessing the validity, responsiveness and meaningfulness of the hidradenitis suppurativa clinical response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment. Br J Dermatol 171:1434\u20131442","journal-title":"Br J Dermatol"},{"key":"2012_CR24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Okun MM, Williams DA et al (2016) Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med 375:422\u2013434","journal-title":"N Engl J Med"},{"key":"2012_CR25","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2015.07.055","volume":"73","author":"JJ Kohorst","year":"2015","unstructured":"Kohorst JJ, Kimball AB, Davis MD (2015) Systemic associations of hidradenitis suppurativa. J Am Acad Dermatol 73:S27\u2013S35","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR26","doi-asserted-by":"crossref","first-page":"7859","DOI":"10.4081\/dr.2018.7859","volume":"10","author":"A Kyriakou","year":"2018","unstructured":"Kyriakou A, Trigoni A, Galanis N, Sotiriadis D, Patsatsi A (2018) Efficacy of adalimumab in moderate to severe hidradenitis suppurativa: real life data. Dermatol Rep 10:7859","journal-title":"Dermatol Rep"},{"key":"2012_CR27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.intimp.2018.03.011","volume":"58","author":"SZ Mai","year":"2018","unstructured":"Mai SZ, Li CJ, Xie XY et al (2018) Increased serum IL-36\u03b1 and IL-36\u03b3 levels in patients with systemic lupus erythematosus: association with disease activity and arthritis. Int Immunopharmacol 58:103\u2013108","journal-title":"Int Immunopharmacol"},{"key":"2012_CR28","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ad.2015.06.004","volume":"106","author":"A Martorell","year":"2015","unstructured":"Martorell A, Garc\u00eda-Mart\u00ednez FJ, Jim\u00e9nez-Gallo D et al (2015) An update on hidradenitis suppurativa (part I): epidemiology, clinical aspects, and definition of disease severity. Actas Dermosifiliogr 106:703\u2013715","journal-title":"Actas Dermosifiliogr"},{"key":"2012_CR29","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/exd.12272","volume":"22","author":"M Mattii","year":"2013","unstructured":"Mattii M, Ayala F, Balato N et al (2013) The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members. Exp Dermatol 22:813\u2013819","journal-title":"Exp Dermatol"},{"key":"2012_CR30","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","volume":"62","author":"\u0141 Matusiak","year":"2010","unstructured":"Matusiak \u0141, Bieniek A, Szepietowski JC (2010) Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol 62:706\u2013708","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jaad.2016.10.042","volume":"76","author":"\u0141 Matusiak","year":"2017","unstructured":"Matusiak \u0141, Szcz\u0119ch J, Bieniek A, Nowicka-Suszko D, Szepietowski JC (2017) Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol 76:670\u2013675","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR32","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","volume":"137","author":"B Moran","year":"2017","unstructured":"Moran B, Sweeney CM, Hughes R et al (2017) Hidradenitis suppurativa is characterized by dysregulation of the Th17: treg cell axis, which is corrected by anti-TNF therapy. J Investig Dermatol 137:2389\u20132395","journal-title":"J Investig Dermatol"},{"key":"2012_CR33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/1346-8138.14198","volume":"45","author":"S Otobe","year":"2018","unstructured":"Otobe S, Sugaya M, Nakajima R et al (2018) Increased interleukin-36\u03b3 expression in skin and sera of patients with atopic dermatitis and mycosis fungoides\/S\u00e9zary syndrome. J Dermatol 45:468\u2013471","journal-title":"J Dermatol"},{"key":"2012_CR34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/jir.2008.0139","volume":"28","author":"R Parsanejad","year":"2008","unstructured":"Parsanejad R, Fields WR, Steichen TJ, Bombick BR, Doolittle DJ (2008) Distinct regulatory profiles of interleukins and chemokines in response to cigarette smoke condensate in normal human bronchial epithelial (NHBE) cells. J Interferon Cytokine Res 28:703\u2013712","journal-title":"J Interferon Cytokine Res"},{"key":"2012_CR35","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/jid.2012.372","volume":"133","author":"AE Pink","year":"2013","unstructured":"Pink AE, Simpson MA, Desai N, Trembath RC, Barker JNW (2013) Gamma-secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. J Investig Dermatol 133:601\u2013607","journal-title":"J Investig Dermatol"},{"key":"2012_CR36","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59:596\u2013601","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/mi.2015.134","volume":"9","author":"SE Russell","year":"2016","unstructured":"Russell SE, Horan RM, Stefanska AM et al (2016) IL-36\u03b1 expression is elevated in ulcerative colitis and promotes colonic inflammation. Mucosal Immunol 9:1193\u20131204","journal-title":"Mucosal Immunol"},{"key":"2012_CR38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2340\/00015555-2794","volume":"98","author":"A Schuch","year":"2018","unstructured":"Schuch A, Fischer T, Boehner A, Biedermann T, Volz T (2018) Successful treatment of severe recalcitrant hidradenitis suppurativa with the interleukin-17A antibody secukinumab. Acta Derm Venereol 98:151\u2013152","journal-title":"Acta Derm Venereol"},{"key":"2012_CR39","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","volume":"71","author":"J Shlyankevich","year":"2014","unstructured":"Shlyankevich J, Chen AJ, Kim GE, Kimball AB (2014) Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case\u2013control analysis. J Am Acad Dermatol 71:1144\u20131150","journal-title":"J Am Acad Dermatol"},{"key":"2012_CR40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89\u2013102","journal-title":"Nat Rev Immunol"},{"key":"2012_CR41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/ijms.13800","volume":"13","author":"K Srikanthan","year":"2016","unstructured":"Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K (2016) Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west virginian population. Int J Med Sci 13:25\u201338","journal-title":"Int J Med Sci"},{"key":"2012_CR42","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/jdv.14389","volume":"31","author":"R Thomi","year":"2017","unstructured":"Thomi R, Kakeda M, Yawalkar N, Schlapbach C, Hunger RE (2017) Increased expression of the interleukin-36 cytokines in lesions of hidradenitis suppurativa. J Eur Acad Dermatol Venereol 31:2091\u20132096","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2012_CR43","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/bjd.15769","volume":"179","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Theut Riis P, Jemec GBE (2018) Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report. Br J Dermatol 179:182\u2013185","journal-title":"Br J Dermatol"},{"key":"2012_CR44","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola L, Rosenwald E, Abel B et al (2012) Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Investig 122:3965\u20133976","journal-title":"J Clin Investig"},{"key":"2012_CR45","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/oby.2010.55","volume":"18","author":"EJ van Asseldonk","year":"2010","unstructured":"van Asseldonk EJ, Stienstra R, Koenen TB et al (2010) The effect of the interleukin-1 cytokine family members IL-1F6 and IL-1F8 on adipocyte differentiation. Obesity (Silver Spring) 18:2234\u20132236","journal-title":"Obesity (Silver Spring)"},{"key":"2012_CR46","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/thx.2003.012468","volume":"59","author":"H van der Vaart","year":"2004","unstructured":"van der Vaart H, Postma DS, Timens W, ten Hacken NH (2004) Acute effects of cigarette smoke on inflammation and oxidative stress: a review. Thorax 59:713\u2013721","journal-title":"Thorax"},{"key":"2012_CR47","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1365-2133.2011.10254.x","volume":"164","author":"HH van der Zee","year":"2011","unstructured":"van der Zee HH, de Ruiter L, van den Broecke DG, Dik WA, Laman JD, Prens EP (2011) Elevated levels of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)-1\u03b2 and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-\u03b1 and IL-1\u03b2. Br J Dermatol 164:1292\u20131298","journal-title":"Br J Dermatol"},{"key":"2012_CR48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","volume":"133","author":"BG Vazquez","year":"2013","unstructured":"Vazquez BG, Alikhan A, Weaver AL, Wetter DA, Davis MD (2013) Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Investig Dermatol 133:97\u2013103","journal-title":"J Investig Dermatol"},{"key":"2012_CR49","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","volume":"118","author":"S Vigne","year":"2011","unstructured":"Vigne S, Palmer G, Lamacchia C et al (2011) IL-36R ligands are potent regulators of dendritic and T cells. Blood 118:5813\u20135823","journal-title":"Blood"},{"key":"2012_CR50","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood-2012-06-439026","volume":"120","author":"S Vigne","year":"2012","unstructured":"Vigne S, Palmer G, Martin P et al (2012) IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells. Blood 120:3478\u20133487","journal-title":"Blood"},{"key":"2012_CR51","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.12787","volume":"170","author":"GR Vinding","year":"2014","unstructured":"Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GB (2014) The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol 170:884\u2013889","journal-title":"Br J Dermatol"},{"key":"2012_CR52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/bjd.17641","volume":"181","author":"ARJV Vossen","year":"2019","unstructured":"Vossen ARJV, Ardon CB, van der Zee HH, Lubberts E, Prens EP (2019) The anti-inflammatory potency of biologics targeting tumour necrosis factor-\u03b1, interleukin (IL)-17A, IL-12\/23 and CD20 in hidradenitis suppurativa: an ex vivo study. Br J Dermatol 181:314\u2013323","journal-title":"Br J Dermatol"},{"key":"2012_CR53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/QCO.0b013e3283428d07","volume":"24","author":"S Yazdanyar","year":"2011","unstructured":"Yazdanyar S, Jemec GB (2011) Hidradenitis suppurativa: a review of cause and treatment. Curr Opin Infect Dis 24:118\u2013123","journal-title":"Curr Opin Infect Dis"},{"key":"2012_CR54","doi-asserted-by":"crossref","first-page":"8980534","DOI":"10.1155\/2017\/8980534","volume":"2017","author":"A \u017bebrowska","year":"2017","unstructured":"\u017bebrowska A, Wo\u017aniacka A, Juczy\u0144ska K et al (2017) Correlation between IL36\u03b1 and IL17 and activity of the disease in selected autoimmune blistering diseases. Mediat Inflamm 2017:8980534","journal-title":"Mediat Inflamm"},{"key":"2012_CR55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jaad.2018.05.040","volume":"80","author":"CC Zouboulis","year":"2019","unstructured":"Zouboulis CC, Okun MM, Prens EP et al (2019) Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa\/acne inversa: 3-year results of a phase 3 open-label extension study. J Am Acad Dermatol 80:60\u201369","journal-title":"J Am Acad Dermatol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-02012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-019-02012-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-02012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T22:33:03Z","timestamp":1612305183000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-019-02012-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["2012"],"URL":"https:\/\/doi.org\/10.1007\/s00403-019-02012-w","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"18 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}